Dr. Michael C. Roach, MD

Dr. Roach practices at Cancer Treatment Center Hawaii in Honolulu, Hawaii.

Dr. Roach's NPI, 1114226735, was assigned on March 22, 2011. Dr. Roach graduated from Duke University School of Medicine in 2011. Dr. Roach holds Hawaii license MD-20574.

Dr. Roach's primary practice is Cancer Treatment Center Hawaii, at 2226 Liliha St, Honolulu, HI 96817 in Honolulu County. The practice phone is (808) 547-6881.

Dr. Roach's primary practice is Cancer Treatment Center Hawaii in Honolulu, Hawaii. Dr. Roach is also affiliated with Straub Benioff Medical Center. The medical group on file is Gamma Knife Center of the Pacific. Dmand AI also links Dr. Roach to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roach practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Roach's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Roach is licensed in Hawaii.

CMS data shows 3,647 Medicare services from Dr. Roach across 25 procedure codes in 2024, for 305 Medicare patients. Medicare paid $473,675 for them. Every service was in an office.

CMS counts 305 Medicare patients who saw Dr. Roach in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Roach's median patient age at 72, with 57% women.

In 2024, Dr. Roach wrote 85 Medicare Part D claims for 42 patients. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $59 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Roach for performance year 2024, reported as part of a group. Dr. Roach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roach as offering telehealth.

Dmand AI links 60 papers to Dr. Roach, published from 2010 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Radiosurgery. Dr. Roach has published most often in Int J Radiat Oncol Biol Phys. Dr. Roach's most frequent co-authors are Clifford Grant Robinson, MD, Parag Jitendra Parikh, MD and Pamela Parker Samson, MD.

Dmand AI links Dr. Roach to 5 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Rectal Neoplasms, Rectal Diseases and Carcinoma, Non-Small-Cell Lung. Washington University School of Medicine sponsors the most, 5.

CMS Open Payments shows 138 general payments to Dr. Roach from 34 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 44% of the total. Varian Medical Systems, Inc. paid the most, $8,180.

Dr. Roach graduated from Duke University School of Medicine in 2011.